Teva wins FDA nod for sublingual film to treat opioid dependence

Teva wins FDA nod for sublingual film to treat opioid dependence

Source: 
Drug Delivery Business News
snippet: 

The FDA last week approved Teva Pharmaceuticals (NYSE:TEVA) Cassipa sublingual film as a maintenance treatment for opioid dependence.